The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
62 | 59 | 32 | 15 |
Growth
|
83 | 45 | 43 | 75 |
Safety
|
59 | 93 | 96 | 84 |
Sentiment
|
54 | 61 | 67 | 38 |
|
80 | 52 | 85 | 50 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
81 | 78 | 70 | 57 |
Opinions Change
|
70 | 50 | 87 | 50 |
Pro Holdings
|
n/a | 43 | 13 | 24 |
Market Pulse
|
37 | 46 | 65 | 57 |
Sentiment
|
54 | 61 | 67 | 38 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
62 | 59 | 32 | 15 |
Growth
|
83 | 45 | 43 | 75 |
|
59 | 93 | 96 | 84 |
Combined
|
88 | 67 | 74 | 71 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
1 | 1 | 1 | 5 |
Price vs. Earnings (P/E)
|
59 | 51 | 29 | 21 |
Price vs. Book (P/B)
|
75 | 77 | 71 | 40 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
62 | 59 | 32 | 15 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
86 | 77 | 73 | 69 |
Profit Growth
|
77 | 4 | 1 | 59 |
Capital Growth
|
67 | 59 | 63 | 53 |
Stock Returns
|
27 | 49 | 41 | 85 |
Growth
|
83 | 45 | 43 | 75 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
66 | 87 | 80 | 87 |
Refinancing
|
79 | 76 | 67 | 31 |
Liquidity
|
4 | 38 | 38 | 40 |
|
59 | 93 | 96 | 84 |
Discover high‑ranked alternatives to OrthoPediatrics and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.